1-2 of 2
Mark Joseph Axelrod, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Combination Effects of B Cell Receptor Pathway Inhibitors (Entospletinib, ONO/GS-4059, and Idelalisib) and a BCL-2 Inhibitor in Primary CLL Cells

Randall Jones, B.A., Mark Joseph Axelrod, PhD, Daniel Tumas, PhD DVM, Christophe Quéva, PhD, Julie Di Paolo, PhD
Journal: Blood
Blood (2015) 126 (23): 1749.
https://doi.org/10.1182/blood.V126.23.1749.1749
Published: 2015
Journal Articles

The Combination of Entospletinib and Vincristine Demonstrates Synergistic Activity in a Broad Panel of Hematological Cancer Cell Lines and Anti-Tumor Efficacy in a DLBCL Xenograft Model

Mark Joseph Axelrod, PhD, Peter Fowles, Jeff Silverman, PhD, Astrid Clarke, PhD, Jennifer Tang, Emma Rousseau, M.S., Heather Kay Webb, PhD, Julie Di Paolo, PhD
Journal: Blood
Blood (2015) 126 (23): 5123.
https://doi.org/10.1182/blood.V126.23.5123.5123
Published: 2015